Home Food & Beverage Food Supplements Nutraceutical Excipients Market

Nutraceutical Excipients Market Size, Share & Trends Analysis Report By Function (Binders & Fillers, Disintegrants, Coatings & Film Formers, Lubricants & Glidants, Sweeteners & Flavour Systems, Others), By Dosage Form (Tablets, Capsules, Gummies & Chewables, Powders & Sachets, Softgels & Liquid-Fill, Others), By Source (Synthetic, Plant-Based, Mineral, Animal-Derived), By End User (Nutraceutical Brand Owners, Contract Manufacturers/CDMOs, Private Label/Retail Brands, Clinical Nutrition Companies), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Devyani Desale | Format:

Nutraceutical Excipients Market Size & Growth Analysis

The global nutraceutical excipients market size was valued at USD 5.6 billion in 2025 and is projected to grow from USD 6.03 billion in 2026 to USD 10.83 billion by 2034, registering a CAGR of 7.6% during the forecast period from 2026 to 2034. North America dominated the nutraceutical excipients market with a market share of 37.4% in 2025.

The nutraceutical excipients market covers binders, fillers, disintegrants, coatings, capsule materials, sweeteners, and texturizers formulated for dietary supplements and functional nutrition. The market demand is reinforced by policy pressure to limit sugars and improve transparency, which prompts brands to shift toward sugar-reduced gummies, shots, and tablets that utilise newer film formers, plant-based capsules, and cleaner carriers. As brands expand convenient formats and healthy-ageing use cases, excipients that enhance palatability, bioavailability, and protection become central to product performance and regulatory confidence.

Market Key Takeaways

Global Market Size & Growth

North America dominated the market with a revenue share of 37.4% in 2025.
Asia Pacific is anticipated to grow at the fastest CAGR of 11.5% during the forecast period.
Based on function, the binders and fillers segment held the highest market share of 27% in 2025.
By Dosage Form, the gummies segment is estimated to register the fastest CAGR growth of 10.5%.
Based on source, the Synthetic excipientscategory dominated the market in 2025 with a revenue share of 36%.
Based on end user, the Contract Manufacturers or CDMOssegment is projected to register the fastest CAGR of 9.8% during the forecast period.
U.S. dominates the market, valued at USD 1,173.61 million in 2024 and reaching USD 1,257.75 million in 2025.
2025 Market Size
USD 5.60 billion
2034 Projected Market Size
USD 10.80 billion
CAGR (2026-2034)
7.60%
Dominating Region
North America
Fastest-Growing Region
Asia Pacific
Nutraceutical Excipients Market Size

Download a Free Sample To learn more about this report.

Function Insights

Binders and fillers dominated the market with a revenue share of 27% in 2025, due to their universal role in tablets and capsules, the most common supplement formats. Materials like microcrystalline cellulose (MCC) and dicalcium phosphate (DCP) provide consistent flow, compressibility, and content uniformity. Even as brands experiment with new delivery formats, binders and fillers remain essential for dose stability and tablet integrity, ensuring they continue to anchor excipient spend globally.

Controlled-release polymers segment is the fastest growing, exhibiting a CAGR of 10.2%, as brands seek to differentiate through targeted or sustained delivery. HPMC and ethylcellulose coatings help improve the stability of sensitive actives, such as probiotics and enzymes, reduce gastric discomfort, and enable colon- or intestine-specific release. These materials also support clean-label demands and low-nitrite requirements by offering plant-based or safer grades.

Nutraceutical Excipients Market Size By Segments

Request Customizationto receive a tailored report.

Dosage Form Insights

Tablets hold the largest market share of 34% due to their low manufacturing costs, scalability, and robust shelf life. They work well in varied climates, support scoring for dose flexibility, and require fewer excipients compared to gummies or RTDs. With mature supply chains for compression-grade excipients and rapid coating systems, tablets will continue to dominate core categories such as multivitamins, minerals, and condition-specific blends.

Gummies are the fastest-growing segment, with a CAGR of 10.5%, due to their taste, convenience, and appeal among younger and female consumers. Advances in pectin-based and vegan formulations support clean-label and allergen-free claims, enhancing the credibility of these formulations. Brands use bold flavours, creative shapes, and beauty- or immunity-focused actives to justify premium pricing. As retail space for chewables expands and consumers increasingly choose “fun” supplement formats, gummies are gaining momentum.

Source Insights

Synthetic excipients lead the market, holding a revenue share of 36%. They are preferred due to their consistency, purity, and proven track record of performance in large-scale manufacturing. They ensure reliable compaction, flow, and disintegration across batches, minimising risks during global launches. With strong pharmacopeial backing and worldwide availability, synthetics enable brands to optimise production efficiency and dual-source materials for reduced supply risk. Even as plant-based demand grows, synthetics remain the backbone for high-speed tablet, capsule, and coating applications.

Plant-based excipients are the fastest-growing segment, with a CAGR of 9.1%, driven by rising demand for vegan, clean-label, and allergen-free products. HPMC capsules commonly replace gelatin shells, while starches and pectins enable the production of organic and sugar-reduced gummies. These ingredients align with retailer and ESG mandates, offering traceable, palm-free, and low-nitrite options. Advances in plant-derived delayed-release coatings are also removing technical barriers, making them suitable for complex formulations, such as probiotics and botanicals.

End User Insights

Nutraceutical Brand Owners dominate the market with a revenue share of 46% in 2025. They control product portfolios, reformulation timelines, and market launches. They rely on excipients to meet evolving clean-label, low-sugar, and performance goals while maintaining manufacturing efficiency. Their scale allows them to co-develop proprietary compression blends or capsule shells directly with suppliers.

Contract Manufacturers or CDMOs are growing at the fastest rate, with a CAGR of 9.8% in 2025, as brands outsource complex, multi-format production. They offer formulation expertise, regulatory support, and turnkey solutions for gummies, delayed-release shells, and microencapsulated actives. Their ability to scale novel delivery formats and meet retailer quality expectations makes them an attractive choice for both established and emerging supplement brands.

Nutraceutical Excipients Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the market in 2025, accounting for 37.40% market share due to mature supplement manufacturing, strong retail and DTC penetration, and clearer compliance pathways that reduce launch risk. The U.S. FDA’s guidance on supplement testing and documentation maintains high quality, favouring proven excipient suppliers. This boosts demand for advanced ingredients, such as plant-based coatings, taste-masking systems, and alternative sweeteners, used in low-sugar gummies, tablets, and shots, making the region a hub for both volume and quality innovation.

  • The U.S. is the central innovation hub, featuring large contract manufacturers and frequent regulatory updates. FDA resources reinforce standards, leading brands to use certified binders, coatings, and capsules. As products cut sugar to meet "healthy" labelling trends, the demand for plant-based film formers and taste-masking systems increases, reinforcing the U.S. as the primary source of volume and innovation.
North America Nutraceutical Excipients Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific's Market Trends

Asia Pacific is emerging as the fastest-growing region with a CAGR of 11.5% from 2026-2034, driven by urban demand for convenient, low and no-sugar functional products and by regulatory nudges that favour transparent labelling. Regional co-manufacturing capacity for gummies and capsules is expanding, while cross-border e-commerce spreads clean-label and vegan capsule preferences. These dynamics widen adoption of HPMC capsules, pectin or modified-starch gummy systems, and rapid film coats designed for humidity stability across tropical markets, fueling APAC’s outsized growth trajectory from a smaller base.

  • Singapore leads innovation and acts as a regulatory model. Nutri-Grade rules incentivise low-sugar products, prompting brands to refine sweeteners and coatings while maintaining product palatability. Due to Singapore’s major role in retail and distribution, compliant, well-formulated products like RTD shots and chewables can quickly scale across the region, boosting demand for high-quality, plant-based excipients.

European Market Trends

Europe is a high-value market defined by strict quality standards and a focus on advanced delivery systems. Brands often utilise specialised capsules and coatings to safeguard sensitive ingredients, such as probiotics, while meeting clean-label requirements. A key highlight is the availability of new, advanced capsules that can target the colon for better delivery of certain actives, showing Europe's leadership in engineering functional dosage forms. The strong push for evidence-based and low-sugar products ensures consistent demand for high-performing taste-masking agents and quality excipients, such as HPMC and ethylcellulose.

  • Germany's advanced ecosystem of excipient suppliers and strict quality expectations supports the use of high-specification materials and complex capsules. The availability of GMP-produced functional capsules locally allows German contract manufacturers to quickly adopt pharmaceutical-grade delivery systems (like colon-targeted shells) for consumer health products, accelerating market launches for differentiated, clean-label European brands.

Latin American Market Trends

Latin America is driven by new supplement regulations and policies aimed at reducing sugar and promoting clearer labelling. Brazil’s ANVISA updated its rules in 2025, clarifying requirements for components and usage limits, which helps formulators comply faster. Mexico’s ongoing front-of-pack labelling rules continue to push for reformulation. As brands standardise labels and cut sugar, they increasingly use natural colours, plant-based film formers, and taste-masking agents, with modern retail channels supporting the scale-up of these new formulations.

  • Brazil acts as the region’s regulatory and manufacturing anchor. The 2025 ANVISA updates provide clear compliance pathways for excipients and claims. With a large pharmacy network and growing demand for functional beverages, local manufacturers are adopting modern formats, such as pectin-based gummy systems and HPMC capsules, for their sugar-reduced products, which supports quicker commercialisation and potential regional export growth.

Middle East and Africa (MEA) Market Trends

The Middle East and Africa market demand is being driven by government policies that focus on sugar reduction and clearer nutrition facts. The UAE’s tiered sugar-based excise tax strongly encourages low- or no-sugar beverages and shots, which rely heavily on advanced sweetener systems and emulsifiers. As modern trade expands and the hot climate requires better stability, the need for high-quality coatings and moisture-controlled capsules increases. The localisation of low-sugar functional products increases demand for plant-based excipients and taste-maskers, starting from a relatively smaller base.

  • The UAE’s new tiered tax directly rewards sugar reduction in beverages, pushing brands to innovate with compliant, low-sugar energy and focus drinks. This policy is expected to increase shelf space for functional shots and supplements. The local environment increases the demand for premium sweeteners, high-performance flavour systems, and plant-based film coatings that are specifically designed to withstand the challenging Gulf climate.

Competitive Landscape

The global nutraceutical excipients market is moderately fragmented, featuring a mix of multinational excipient manufacturers, capsule and coating specialists, flavour and texture system experts, and regional CDMOs. A long tail of regional and niche players continues to compete in areas like taste-masking, targeted release, or vegan capsules. Key differentiators include GMP-grade quality, clean-label options (such as low-nitrite cellulose), and scalability in fast-growing formats like gummies and RTDs.

Roquette Pharma Solutions: An Emerging Player

Roquette Pharma Solutions is emerging as a key integrated partner following the acquisition of IFF Pharma Solutions and Qualicaps. This move gives Roquette end-to-end control over plant-based binders, coatings, sweeteners, and HPMC capsule shells, aligned with strong demand for clean-label and vegan formats. The wider footprint improves customer collaboration, supporting brands from prototype to commercial launch in tablets, gummies, and modified-release capsules.

Latest News

  • In August 2025, Roquette launched METHOCEL™ Low-Nitrite HPMC (≤200 ppb), a safer-by-design excipient that helps supplement brands comply with rising global nitrosamine controls. The product immediately garnered industry attention for its clean-label use in gummy, tablet, and capsule formulations.

List of Key and Emerging Players in Nutraceutical Excipients Market

Roquette (incl. Qualicaps)
Evonik Health Care
Ashland
Colorcon
BASF Nutrition & Health / LDC Ingredients (post-transaction)
DFE Pharma
JRS Pharma
MEGGLE
Shin-Etsu Chemical
Gattefossé
Lubrizol Life Science – Health
Ingredion
Kerry Group
Tate & Lyle
DSM-Firmenich
Lonza Capsules & Health
ACG
Qualicaps
CapsCanada
IMCD
SPI Pharma
DuPont/IFF

Key Industry Developments

June 2026
Kerry Group expanded its nutraceutical ingredient solutions portfolio with new formulation technologies for functional foods and dietary supplements. The company focused on improving bioavailability, taste, and consumer-friendly delivery formats for nutraceutical products.
March 2026
Roquette expanded its plant-based excipients portfolio with new ingredient solutions for nutraceutical and supplement manufacturers. The developments support improved tablet processing, stability, and formulation performance.
January 2026
Ashland expanded its health and wellness ingredient portfolio with advanced excipient solutions for dietary supplements. The company focused on improving functionality, texture, and performance of nutraceutical formulations.
October 2025
Lubrizol expanded its specialty ingredient solutions for nutraceutical applications with new excipient technologies. The initiatives support manufacturers developing innovative supplement formats, including capsules, tablets, and functional delivery systems.

Report Scope

Segmentation

By Function 10
  • Binders and fillers
  • Disintegrants
  • Coatings and film formers
  • Lubricants and glidants
  • Sweeteners and flavour systems
  • Solubilisers and emulsifiers
  • Preservatives and antioxidants
  • Controlled-release polymers
  • Colorants
  • Other carriers
By Dosage Form 6
  • Tablets
  • Capsules
  • Gummies and chewables
  • Powders and sachets
  • RTD liquids and shots
  • Softgels and liquid-fill
By Source 4
  • Synthetic
  • Plant-based
  • Mineral
  • Animal-derived
By End User 4
  • Nutraceutical brand owners
  • Contract manufacturers/CDMOs
  • Private label/retail brands
  • Clinical nutrition companies

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Roquette (incl. Qualicaps) · Evonik Health Care · Ashland · Colorcon · BASF Nutrition & Health / LDC Ingredients (post-transaction)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The nutraceutical excipients market size is valued at USD 6.03 Billion in 2026 and is projected to reach USD 10.83 Billion by 2034, at a CAGR of 7.6% during the forecast period 2026-2034.

North America dominated the market with a share of 37.4% in 2025.

The leading brands in this market are Roquette, Evonik Health Care, Ashland, Colorcon, BASF Nutrition & Health / LDC Ingredients.

The nutraceutical excipients market is projected to grow at a CAGR of 7.6% during the forecast period of 2026 2034.
About the Author
Devyani Desale
Devyani Desale
Research Analyst

Devyani Desale is an F&B research professional with over two years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the food and beverage sector. She provides actionable insights into market dynamics, industry trends, competitive landscapes, and emerging growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, competitive scenarios, consumer trends, and industry developments through structured research and analytical methodologies. She focuses on translating market data into clear, relevant insights that support business strategy and informed decision-making.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: